Identity
- Security key
- 13756
- Ticker
- CRBP
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2014-10-24
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- CRBP
Detail
Enriched 2026-08-14 20:47
- Market cap
- $188,771,019.68
- Shares outstanding (class)
- 18,527,795
- Shares outstanding (weighted)
- 19,341,293
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 36
- Location
- NORWOOD, MA
- Homepage
- https://www.corbuspharma.com
- Description
Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
Market cap and share counts drift.